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Abstract
Nerve injury leads to a neuropathic pain state that results from central sensitization. This phenomenom is mediated by NMDA 
receptors and may involve the production of nitric oxide (NO). In this study, we investigated the expression of the neuronal 
isoform of NO synthase (nNOS) in the spinal cord of 3-month-old male, Wistar rats after sciatic nerve transection (SNT). Our 
attention was focused on the dorsal part of L3-L5 segments receiving sensory inputs from the sciatic nerve. SNT resulted in the 
development of neuropathic pain symptoms confirmed by evaluating mechanical hyperalgesia (Randall and Selitto test) and 
allodynia (von Frey hair test). Control animals did not present any alteration (sham-animals). The selective inhibitor of nNOS, 
7-nitroindazole (0.2 and 2 µg in 50 µL), blocked hyperalgesia and allodynia induced by SNT. Immunohistochemical analysis 
showed that nNOS was increased (48% by day 30) in the lumbar spinal cord after SNT. This increase was observed near the 
central canal (Rexed’s lamina X) and also in lamina I-IV of the dorsal horn. Real-time PCR results indicated an increase of nNOS 
mRNA detected from 1 to 30 days after SNT, with the highest increase observed 1 day after injury (1469%). Immunoblotting 
confirmed the increase of nNOS in the spinal cord between 1 and 15 days post-lesion (20%), reaching the greatest increase 
(60%) 30 days after surgery. The present findings demonstrate an increase of nNOS after peripheral nerve injury that may 
contribute to the increase of NO production observed after peripheral neuropathy.
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Introduction
Neuropathic pain is initiated by a primary lesion or 
dysfunction of the nervous system. In spite of extensive 
investigations, the mechanism of neuropathic pain is still 
unclear. Neuropathic pain is much more difficult to treat 
than nociceptive pain. The therapeutic approaches include 
the use of gabapentin, opioids (mainly morphine) and, 
more recently, pregabalin. However, these treatments are 
not very effective. Thus, neuropathic pain could interfere 
with the quality of life of patients, representing a serious 
clinical problem. 
Animal models are relevant for the understanding of the 
mechanisms and pathophysiology of human neuropathic 
pain. Among these models, transection of the rat sciatic 
nerve produces abnormalities in pain sensation reminiscent 
of those observed in humans, and it represents a good model 
to study both nerve regeneration and neuropathic pain.
Several lines of evidence have indicated that nitric oxide 
(NO) is an important mediator of nerve injury and may be 
responsible for pain-linked behavior in animals. Peripheral 
nerve injury may result in an increased excitability of spinal 
cord neurons through activation of nociceptive afferents, 
leading to activation of N-methyl-D-aspartate receptors 
and subsequent spinal production of NO (1). Therefore, 
an altered expression of spinal NO synthase (NOS) and its 
enhanced catalytic activity may contribute to neuroplasticity 
after nerve injury and may play an important role in central 
sensitization. However, pharmacological evidence regard-
ing the role of spinal NO in the development of nerve injury-
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evoked allodynia or hyperalgesia has been conflicting. 
NO is a biological messenger molecule synthesized 
by three isoforms of NOS, which diffuses from the site of 
production across cellular membranes. All three isoforms 
of NOS are present in the nervous system, namely the 
constitutive neuronal (nNOS) and endothelial isoforms 
(eNOS), and the inducible isoform (iNOS) (2). nNOS is 
up-regulated after peripheral inflammation, iNOS is mainly 
absent in neural tissues under normal conditions, but is 
up-regulated in inflammation, while eNOS is present in 
the brain vasculature. nNOS is present in the spinal cord 
of rats, predominantly in the superficial dorsal horn (Rexed 
laminae I and II), in the area around the central canal 
(lamina X) and in the intermediolateral nucleus column 
of the thoracic, upper lumbar, and sacral segments (3). 
Strong up-regulation of NOS expression has been detected 
in large neurons of laminae III and IV after sciatic nerve 
transection (SNT) (4).
The effects of nerve transection on neuronal nitrergic 
activity have been extensively investigated, and the data 
are contradictory. Indeed, some investigators observed that 
treatment with NOS inhibitors interferes with allodynia and 
hyperalgesia (5,6) induced by rat nerve injury, whereas 
others have reported that nNOS inhibitors have no effect 
on the hyperalgesia induced by nerve injury (7,8). 
In light of these conflicting results and despite the fact 
that in vivo studies suggest an important role for spinal cord 
NO in the transmission of pain signals, the possible partici-
pation of NO after SNT and its effects on the lumbar spinal 
cord have not been evaluated. The aim of the present study 
was to investigate nNOS expression in the lumbar spinal 
cord of adult rats after SNT using immunohistochemistry, 
Western blot, and real-time PCR assays together with the 
analysis of nociceptive behavior. Attention was focused on 
the dorsal part of the cord (L3-L5 segments), which receives 
sensory inputs from the sciatic nerve (4). In addition, we also 
evaluated the effect of the administration of 7-nitroindazole 
(7-NI), a selective nNOS inhibitor, on the development of 
hyperalgesia and allodynia after SNT.
Material and Methods
 
Animals
Male Wistar rats weighing 200 to 250 g (approximately 
3 months of age) were used. They were housed individually 
and maintained on a 12-h light/dark cycle. All procedures 
were approved by the Animal Care Committee of the Uni-
versity of São Paulo (protocol #071/2005).
Surgical procedure
Animals were anesthetized with intramuscular injec-
tions of ketamine (5 mg/100 g body weight) and xylazine 
(1 mg/100 g body weight), both from Sespo Ltda. (Brazil). 
The right sciatic nerve of the animal was exposed at the 
mid-thigh level and a short segment (5 mm) of the nerve was 
removed. Sham-operated animals (N = 20) were subjected 
to an identical surgical procedure but not SNT and served 
as controls. Animals used for immunohistochemistry (N = 
32), immunoblotting (N = 24) and real-time PCR (N = 24) 
were anesthetized and perfused and killed by cervical dis-
location at 1, 7, 15, and 30 days after SNT and the lumbar 
segments of the spinal cord were removed by laminectomy. 
Prior to sacrifice, all rats were tested for sensitivity to noxious 
mechanical stimulation of the hind paw using the Randall 
and Selitto and von Frey tests (described below).
Intrathecal injections
Lumbar puncture was performed as described previ-
ously (9). Briefly, a sterile 23-gauge hypodermic needle 
with the plastic hub removed was attached to a sterile 
polyethylene tube (PE-50, Becton Dickinson, USA) and the 
open end of the PE-50 was attached to a 50-µL Hamilton 
syringe for drug delivery. Puncture was made by inserting 
the tube between lumbar vertebrae L5 and L6. Successful 
subarachnoid entry was confirmed by immediate manifesta-
tion of a characteristic tail flick response, and later by visual 
inspection of Evan’s blue dye after euthanasia. 
In order to evaluate the involvement of nNOS, 7-NI (0.2 
and 2 µg in 50 µL, N = 5; Sigma-Aldrich, USA), a selective 
nNOS inhibitor, or vehicle (50 µL distilled water, N = 5) 
was injected into the spinal cord by intrathecal route, 60 
min before behavioral testing in each experimental group 
(at 1, 7, 15, and 30 days post-lesion). The drug solution 
was prepared fresh just before the injection, by dissolving 
the drug in distilled water. Behavioral signs of mechanical 
hyperalgesia and allodynia were measured before and 1, 
2, 4, and 6 h after the injections. The dose used was based 
on our previous studies (9) that indicated that 0.2 and 2.0 
µg/rat 7-NI were sufficient to block neuronal nNOS, allowing 
mechanical hyperalgesia.
Upon completion of behavioral testing and euthanasia, 
correct catheter placement was confirmed visually and only 
results from rats in which the Evans Blue dye was restricted 
to and uniformly distributed in the intrathecal space with no 
apparent leakage were included in the analysis.
Evaluation of pain threshold
Peripheral nerve injury was induced by specific transec-
tion of the sciatic nerve, which innervates the plantar side 
of the rat hind paw. The development of neuropathic pain 
symptoms in the hind paw was evaluated by testing me-
chanical hyperalgesia (Randall and Selitto test) (10) and 
allodynia (von Frey hair test) (11). Both sensory tests were 
used because of literature data showing that SNT induces 
hyperalgesia and allodynia of the ipsilateral hind paw.
Mechanical hyperalgesia (Randall and Selitto test). An 
Ugo-Basile pressure apparatus (10) was used to assess 
pressure pain thresholds prior to surgery and again at dif-
ferent times thereafter. Testing was blind in regard to group 
designation. Briefly, increasing force (16 g/s) was applied 
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to the right hind paw. The force needed to induce paw 
withdrawal was recorded as the pain threshold. To reduce 
stress, the rats were habituated to the testing procedure 
the day before the experiment (12).
Low threshold mechanical allodynia (von Frey test). 
The von Frey test (11) was used to assess low-threshold 
mechanical pain thresholds prior to surgery and again at 
different times thereafter. Testing was blind in regard to 
group designation. This test was performed as described 
in detail (9). Briefly, a logarithmic series of 10 calibrated 
Semmes-Weinstein monofilaments (von Frey hair test, 
Stoelting, USA) were applied to the middle of the plantar 
surface of the right hind paw, for a maximum of 10 s to 
determine the threshold intensity of the stiffness stimulus 
required to elicit a paw withdrawal response. Log stiffness 
of the hairs is determined by log10 (mg x 10) and ranges 
from 3.61 (0.407 g) to 5.18 (15.136 g). Baseline assess-
ment was initiated with the 0.2041-g hair. In the event of 
paw withdrawal, the same hair was again presented 60-
90 s later. If the response was again elicited, the 0.407 
g monofilament was presented. In the absence of a paw 
withdrawal response to the 0.407 g stimulus, the next 
stronger monofilament was presented (0.692 g). The 
monofilament that elicited a clear response was recorded, 
and was presented once again 30-60 s later. If the animal 
withdrew its paw in two consecutive trials with the same 
stiffness value, no further von Frey hairs were tested. How-
ever, in the absence of a response to the initial 0.2041-g 
monofilament, presentation of monofilaments continued 
in ascending order until two consecutive responses were 
elicited from the same monofilament. All single responses 
were recorded, but assessment was complete only after 
two consecutive responses were elicited from the same 
monofilament. Failure to respond to the strongest stimulus 
(15.136 g) was considered to be the cut-off value. Response 
to the weakest stimulus (0.407 g) was considered to be the 
lower cut-off value for that time. To reduce stress, rats were 
habituated to the experimental environment daily for 4 days 
before the experiments. Behavioral responses were used 
to calculate the 50% paw withdrawal threshold (absolute 
threshold), by fitting a Gaussian integral psychometric 
function using a maximum-likelihood fitting method. This 
fitting method allows parametric analyses (13).
RNA isolation, cDNA synthesis and real-time PCR 
Tissue from the ipsilateral and contralateral side of the 
lumbar spinal cord was homogenized in 1 mL TRIzol (In-
vitrogen, USA) with a homogenizer (Kinematica Polytron® 
PT 2100, USA) and total RNA was isolated following the 
manufacturer’s suggested protocol. Total RNA (1 µg) was 
reverse transcribed into cDNA using 200 U M-MLV reverse 
transcriptase and oligo-dT as a primer (Invitrogen).
The real-time PCR system consisted of 250-nM primers, 
50 ng cDNA samples, and 1X SYBR® Green PCR Master 
Mix (Applied Biosystems, USA). Using the Rotor-Gene 
3000 Real-time PCR detection system (Corbett Research, 
Australia), PCR cycling conditions were set as follows: 
after initial activation at 50°C for 2 min and 95°C for 10 
min, 40 cycles of 95°C for 15 s and 60°C for 1 min; then 
melt curve analysis was performed by heating samples 
from 65° to 99°C (1°C increment changes at 5-s intervals). 
All sample measurements were performed in duplicate. 
The following primers were used: nNOS sense: 5’-GTC 
GCATTCAACAGCGTCTC-3; nNOS antisense: 5’-CCC 
AAAGGCACAGAAGTGG-3’ and GAPDH sense: 5’-GA 
TGCTGGTGCTGAGTATGTCG-3’; GAPDH antisense: 
5’-GTGGTGCAGGATGCATTGCTGA-3’, which resulted in 
163- and 197-bp amplicons, respectively (14). 
Sample cycle threshold values were determined from 
plots of normalized fluorescence versus PCR cycle number 
during exponential amplification. Standard curves for all 
primer amplifications were generated by plotting average 
cycle threshold values against the logarithm of the quantity 
of target template molecules.
All quantitations were normalized to the endogenous 
control (GAPDH). The relative quantitation value of each 
target gene was analyzed using a comparative CT method 
(15). The following formula (2-ΔΔCT) was used to calcu-
late the relative amount of the transcript in the sample 
and normalized to an endogenous reference (GAPDH): 
2-ΔΔCT, where ΔCT is the difference in CT between the 
gene of interest and GAPDH, and ΔΔCT for the sample = 
mean ΔCT of the sample - mean ΔCT of the control sample 
(used as calibration).
Immunoblotting
Naive and sham rats and rats subjected to transection 
of the sciatic nerve were sacrificed by cervical dislocation 
and the ipsilateral and contralateral sides of the lumbar 
spinal cord were collected and homogenized in an extrac-
tion buffer containing 100 mM Tris, pH 7.4, 10 mM EDTA, 
2 mM PMSF, and 10 µg/mL aprotinin. After extraction, the 
homogenates were centrifuged at 11.5 g for 20 min and the 
protein concentration of the supernatant was determined 
using the Bradford protein assay with albumin as standard 
(Bio-Rad, USA) (16). Samples containing 100 µg protein 
were loaded on a 6.5% acrylamide gel and electrotransferred 
to nitrocellulose membranes using a Trans-Blot cell system 
(Bio-Rad). After transfer, the membranes were treated for 4 
h at room temperature with a blocking solution containing 
5% powdered milk, washed and incubated overnight at 4°C 
with a mouse monoclonal antibody against nNOS (1:2000, 
Sigma, USA). The membranes were then washed and 
incubated for 2 h at room temperature with a peroxidase-
conjugated anti-mouse antibody diluted 1:10,000 (Amer-
sham Biosciences, UK). β-actin was used as an endogenous 
control (1:1000, Sigma). The specifically bound antibody 
was visualized using a chemoluminescence kit (Amersham 
Biosciences). The blot was analyzed densitometrically using 
NIH-Scion Image 4.0.2 (Scion Corporation, USA). 
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Immunohistochemistry and image analysis
After the appropriate survival time, the animals were 
anesthetized deeply with ketamine and xylazine and per-
fused through the heart with phosphate-buffered saline and 
4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 
7.4. The lumbar spinal cord (L3-L5) was then removed and 
post-fixed for 4 h in 4% paraformaldehyde. The spinal cord 
was transferred to a 30% sucrose solution in PB to ensure 
cryoprotection, which lasted for 48 h, and transverse sections 
(30 µm) were obtained with a sliding microtome adapted for 
cryosectioning. Free-floating sections were incubated with a 
mouse monoclonal antibody against nNOS (Sigma) diluted 
1:1000 in PB containing 0.3% Triton X-100 and 5% normal goat 
serum. Incubations with the primary antibody were conducted 
overnight at 24°C. The sections were then washed three times 
for 10 min each in PB and incubated with a biotinylated goat 
anti-mouse serum (Vector, USA) diluted 1:200 in PB for 2 h at 
24°C. The sections were washed again in PB as above and 
incubated with the avidin-biotin-peroxidase complex (ABC Elite, 
Vector). After washing, the sections were reacted with 0.05% 
3-3’-diaminobenzidine and 0.01% hydrogen peroxide in PB. 
Intensification was conducted with 0.05% osmium tetroxide 
in water. The sections were mounted on gelatinized slides, 
dehydrated, cleared, and coverslipped. The material was 
analyzed under a light microscope and digital images were 
collected. Controls for immunostaining included the omis-
sion of the primary antibody and its replacement with normal 
mouse serum, which completely eliminated the staining. It 
should be stressed that the antibody used here has been 
extensively tested and characterized (14). All lumbar spinal 
cords processed for immunohistochemistry were subjected 
to quantitative analysis, which involved 10 sections from each 
lumbar spinal cord processed from each experimental or control 
rat. Each section was labeled to avoid repeated counts. Data 
are reported as the numbers of nNOs-positive cells. For the 
comparative analyses of the number of cells, we considered the 
controls for each period studied as 100%. Data are reported 
as means ± SEM. 
Statistical analysis
Data were analyzed statistically by analysis of variance 
(ANOVA) and sequential differences between means were 
tested by Tukey contrast analysis at P < 0.05 (17). Data from 
the von Frey test were analyzed as the interpolated 50% 
threshold (absolute threshold) in log base 10 of stimulus 
intensity (monofilament stiffness in milligrams x 10). 
Results
Evaluation of hyperalgesia and allodynia
Rats submitted to SNT developed a protective behav-
ior characterized by guarding of the ipsilateral hind paw, 
which is a sign of neuropathic pain. The SNT induced 
a significant decrease of the mechanical pain threshold 
(Figure 1A), as measured by the Randall and Selitto test, 
and reduced the withdrawal threshold as measured by the 
von Frey test (Figure 1B). These alterations were detected 
as early as on day 1 and persisted at least 1 month after 
surgery. Sham-operated animals (taken as control) did not 
present any alteration of the withdrawal threshold (Figure 
1). No significant differences in paw withdrawal frequency 
were observed between measurements or at any time 
post-transection on the contralateral side of injury (data 
not shown). 
Effect of intrathecal administration of an nNOS 
inhibitor on hyperalgesia and allodynia induced by 
sciatic nerve transection
The intrathecal administration of 7-NI (0.2 µg in 50 
µL), a selective inhibitor of the neuronal isoform of NOS, 
significantly inhibited hyperalgesia (Figure 2A) and allo-
dynia (Figure 2B) induced by nerve SNT on days 7 and 15 
Figure 1. Hyperalgesia and allodynia induced by sciatic nerve transection. The paw threshold was estimated 
in the rat paw pressure test (A) and low-threshold mechanical allodynia was measured using the von Frey test 
(B). These tests were applied before lesion (BL) and on days 1, 7, 15, and 30 after surgery. Sham animals were 
used as controls. Data are reported as means ± SEM for 6 rats. *P < 0.05 compared to sham rats (one-way 
ANOVA followed by the Tukey test). 
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post-lesion. To confirm these results, we also administered a 
high dose (2 µg in 50 µL) of the same inhibitor (Figure 2C and 
D). This treatment decreased hyperalgesia and allodynia 
on day 30 after SNT. This inhibition was observed from 1 
to 4 h after treatment, disappearing after 6 h. No significant 
differences were observed on day 1 after transection for 
either dose used (Figure 2). 
Administration of 7-NI per se did not change the pain 
threshold (pain threshold = 70 ± 2.1, 72 ± 4.1, 68 ± 3.2, 
and 75 ± 3.3 g; low-mechanical threshold (log mg x 10) = 
5.05 ± 0.2, 4.95 ± 0.4, 4.88 ± 0.2, and 5.00 ± 0.5 g at 1, 2, 
4, and 6 h after treatment, respectively).
nNOS mRNA expression evaluated by real-time PCR
Semi-quantitative real-time PCR was used to detect 
nNOS mRNA expression in lumbar spinal cord tissue. 
GAPDH was determined as a suitable endogenous control 
(average CT = 17.28 ± 0.28).
Compared with the ipsilateral side of sham animals 
(taken as controls), nNOS transcript levels were significantly 
increased after all post-lesion periods tested (Figure 3). 
Maximum induction of 1469.0 ± 35.6% was observed on 
day 1 post-lesion. Seven to 30 days after lesion, the nNOS 
gene was still up-regulated: 488.0 ± 21.9% by day 7 (P < 
0.001), 448.0 ± 59.0% by day 15 (P < 0.001), and 453.2 
± 31.1% by day 30 (P < 0.001). No significant differences 
were observed between the contralateral and ipsilateral 
sides from experimental animals (1.00 ± 1.22 vs 0.50 ± 
1.27 by day 7, 1.00 ± 1.12 vs 1.46 ± 1.47 by day 15, and 
1.00 ± 0.55 vs 0.93 ± 0.99 by day 30).
The contralateral side from sham-operated and the 
contralateral side from naive animals (taken as controls) ex-
hibited similar nNOS mRNA (1.00 ± 0.73 vs 1.29 ± 0.20). 
Immunoblotting
We identified a single labeled nNOS-positive band 
of about 150 kDa in extracts of both sides of the lumbar 
spinal cord of both sham and experimental animals after 
SNT. Figure 4 shows an increase of nNOS protein levels 
on the ipsilateral side from experimental animals when 
compared to the ipsilateral side from sham rats, taken as 
100%. Densitometric analysis revealed that the increase 
Figure 2. Effect of 7-nitroindazole on the hyperalgesia and allodynia induced by sciatic nerve transection. The pain threshold was es-
timated by the rat paw pressure test (A,C) and by the von Frey hair test (B,D) applied after transection. 7-Nitroindazole (7-NI, 0.2 and 
2 µg/50 µL) or saline (control group) was administered by the intrathecal route. Both doses of 7-NI were employed in all experimental 
groups. BL = before lesion. Data are reported as means ± SEM for 6 rats. *P < 0.05 compared to lesioned + saline-treated rats (one-
way ANOVA followed by the Tukey test). 
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of nNOS expression started on the first day after lesion: 
21.0 ± 2.1% by day 1 (P < 0.01), 22.0 ± 0.6% by day 7 (P < 
0.01), 19.0 ± 2.3% by day 15 (P < 0.01), and reaching the 
greatest increase after 30 days (58.0 ± 2.7%, P < 0.001). 
β-actin was used as an endogenous control, and no differ-
ences were observed between control and experimental 
sides at any of the times tested (Figure 4). 
The contralateral side from sham-operated and from 
naive animals (taken as controls) exhibited the same nNOS 
protein levels (data not shown). 
Immunohistochemistry
We examined the expression of nNOS in dorsal lumbar 
rat spinal cord sections (L3-L5) from transected rats. Mea-
surements were performed of neurons of the ipsilateral (right) 
and contralateral (left) sides in relation to the transected 
nerve, on the ipsilateral (right) side of sham-operated rats, 
and on the right side of control (naive) animals. 
nNOS immunoreactivity was detected in the lumbar 
spinal cord under normal conditions. A moderate number 
of cells labeled for nNOS was observed on both sides of 
the lumbar spinal cord of naive (Figure 5A) and sham rats 
(Figure 5B), and on the contralateral side (taken as a control 
for the operated animals, Figures 5 and 6A,B) of the lum-
bar spinal cord of experimental rats. These neurons were 
located in the dorsal horn of the spinal cord (Figure 6) as 
well as around the central canal (Figure 5). It is important to 
point out that the dorsal part of the spinal cord was analyzed. 
It receives sensory inputs from the sciatic nerve, since the 
ventral part consisting of sciatic nerve motor neurons was 
not the objective of this study. 
After transection of the sciatic nerve, there was a 
marked increase in the number of lumbar cells that were 
nNOS-immunoreactive on the ipsilateral side (lesion side) 
compared to control (Figure 7). This increase was observed 
around the central canal, lamina X (Figure 5C-F), and also 
in lamina I-IV of the dorsal horn (Figure 6). In addition, 
there was also an increase in the density of labeled cells 
in the lumbar area encompassing the dorsal and central 
portions of the lumbar spinal cord that started on day 1 after 
SNT (quantification in Figure 7). One day after transection, 
there was an increase of approximately 19.0 ± 0.4% (P < 
0.01) in the number of nNOS-positive neurons compared to 
control, and this appeared to increase thereafter to 22.0 ± 
0.3% by day 7 (P < 0.01) and to 35.0 ± 1.0% by day 15 (P 
< 0.01), reaching the greatest increase after 30 days (48.0 
± 0.6%, P < 0.001) (Figure 7). No differences in nNOS im-
munoreactivity were observed in sham-operated animals 
when compared to the contralateral side of experimental 
rats (taken as a control for the operated animals).
Discussion
In this study, we investigated the regulation of spinal 
nNOS during the development of neuropathic pain states 
induced by SNT. Nerve transection induces the develop-
ment of hyperalgesia and allodynia, detected here from 
day 1 to day 30 post-lesion, in agreement with previous 
observations (18,19).
To investigate the involvement of spinal NO in the 
nociceptive effect induced by nerve transection, we admin-
istered 7-NI, a selective inhibitor of the neuronal isoform 
of NOS, by an intrathecal route. This inhibitor was able to 
block hyperalgesia and allodynia induced on days 7, 15 and 
Figure 3. Expression of neuronal nitric oxide synthase (nNOS) 
mRNA in the lumbar spinal cord after lesion. Data are reported as 
means ± SEM for 6 rats. *P < 0.001 compared to sham animals 
(one-way ANOVA followed by the Tukey test).
Figura 4. Densitometric analysis of neuronal nitric oxide syn-
thase (nNOS) protein levels from lumbar spinal cord. The nor-
malized average between sham and experimental groups (sciatic 
nerve transection, SNT) is reported. Data for sham animals were 
taken as 100%. Data are reported as means ± SEM for 6 rats. 
*P < 0.05 compared to sham animals (one-way ANOVA followed 
by the Tukey test). 
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Figure 5. Digital images of neuronal nitric oxide synthase (nNOS) immunostaining around the central canal of the rat spinal cord after 
transection of the sciatic nerve. The images show nNOS-immunoreactive cells (arrows) around the central canal (CONTRA = contralat-
eral; IPSI = ipsilateral). Panels A and B show naive and sham animals, respectively (at day 15 after surgery). Panels C-F show images 
at different times after lesion (1, 7, 15, and 30 days, respectively).
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30 after SNT. On the other hand, we did not observe any 
behavioral effect of the nNOS inhibitor on day 1 after injury. 
These results suggest that NO played an important role in 
the neuropathic pain process but did not participate in the 
nociceptive phenomena in the early periods after SNT. 
The role of NO in several systems remains controversial 
and complex. It is well demonstrated that there is an increase 
of NOS associated with hyperalgesia caused by nerve injury. 
Furthermore, a large body of evidence supports a role of 
spinal NO in the development and maintenance of hype-
ralgesia, and also shows that nNOS inhibition decreases 
hyperalgesia in models of acute and chronic pain (20,21). 
Our results agree with the literature and also point out the 
importance of the activity of the spinal neuronal isoform of 
NOS to the nociceptive effect induced by nerve injury. 
Despite this evidence, it is important to stress that, in our 
study, inhibition of nociceptive pain induced by intrathecal 
administration of the nNOS inhibitor could also result from 
inhibition of peripheral nNOS. In fact, several data have 
Figure 6. Digital images of neuronal nitric oxide synthase (nNOS) immunostaining in the dorsal horn of the rat spinal cord after sciatic nerve transec-
tion (SNT). The images show nNOS-immunoreactive cells (arrows) in the dorsal horn of the spinal cord (laminae I-IV) and around the central canal 
(contralateral - CONTRA, lamina X). Panels A and C show whole sections of the lumbar spinal cord at 15 and 30 days after SNT, respectively. Pan-
els B and D show the ipsilateral (IPSI) side of the spinal cord of rats sacrificed 15 and 30 days post-lesion, respectively, at higher magnification.
Figure 7. Neuronal nitric oxide synthase (nNOS) expression in the 
rat dorso-central lumbar spinal cord after sciatic nerve transection 
(SNT). Analysis of immunohistochemistry data from the ipsilateral 
side of the spinal cord (L3-L5 segments) in relation to the contral-
ateral side (taken as control, 100%). Data are reported as means 
± SEM for 6 operated rats normalized to 6 control rats. *P < 0.05 
compared to the contralateral side (one-way ANOVA followed by the 
Tukey test).
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